D. van Duin

Molecular Medicine · 2017–2020

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom D. van Duin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. L. Poirel
  2. P. Nordmann
  3. T. Walsh
  4. Amy Mathers

Papers from D. van Duin's perspective

Ordered by how strongly the researchers D. van Duin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. OXA-48-like carbapenemases: the phantom menace. (Journal of Antimicrobial Chemotherapy)
  2. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (Clinical Microbiology and Infection)
  3. Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy)
  4. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India (Antimicrobial Agents and Chemotherapy)
  5. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study (Lancet. Infectious Diseases (Print))
  6. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases (Lancet. Infectious Diseases (Print))
  7. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy)
  8. Emerging carbapenemases in Gram-negative aerobes. (Clinical Microbiology and Infection)
  9. The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae (Clinical Microbiology Reviews)
  10. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. (Lancet. Infectious Diseases (Print))

Their papers